{"cluster": 36, "subcluster": 37, "abstract_summ": "COVID-19 is a new clinical syndrome characterized by respiratory symptoms with variable degrees of severity, from mild upper respiratory illness to severe interstitial pneumonia and acute respiratory distress syndrome aggravated by thrombosis in pulmonary microcirculation.The causative agent, SARS-CoV-2 was the third coronavirus responsible for causing major disease outbreaks in human population after Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) caused by SARS-CoV and MERS-CoV respectively.Early observations indicated that cardiovascular disease (CVD) patients are at higher risk of progression to severe respiratory manifestations of COVID-19 including acute respiratory distress syndrome.Finally, it includes arguments in favour of adding COVID-19 to the spectrum of the recently defined \u2018hyperferritinemic syndrome\u2019, which already includes adult-onset Still\u2019s disease, macrophage activation syndrome, septic shock and catastrophic anti-phospholipid syndrome.Some of the articles being published during the severe acute respiratory syndrome\u2013coronavirus (SARS-CoV)-2 pandemic highlight a link between severe forms of coronavirus disease 2019 (COVID-19) and the so-called cytokine storm, also with increased ferritin levels.", "title_summ": "Beware of the same storm that has a different originSerum albumin-mediated strategy for the effective targeting of SARS-CoV-2Perspectives for the use of therapeutic Botulinum toxin as a multifaceted candidate drug to attenuate COVID-19Platelets to surrogate lung inflammation in COVID-19 PatientsMolecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK SignalingInflammation, Immunity and Immunogenetics in COVID-19: A Narrative ReviewStorm, typhoon, cyclone or hurricane in patients with COVID-19?SARS-CoV-2 and COVID-19: between pathophysiology complexity and therapeutic uncertainty.", "title_abstract_phrases": "COVID-19 is a new clinical syndrome characterized by respiratory symptoms with variable degrees of severity, from mild upper respiratory illness to severe interstitial pneumonia and acute respiratory distress syndrome aggravated by thrombosis in pulmonary microcirculation.The causative agent, SARS-CoV-2 was the third coronavirus responsible for causing major disease outbreaks in human population after Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) caused by SARS-CoV and MERS-CoV respectively.Early observations indicated that cardiovascular disease (CVD) patients are at higher risk of progression to severe respiratory manifestations of COVID-19 including acute respiratory distress syndrome.Finally, it includes arguments in favour of adding COVID-19 to the spectrum of the recently defined \u2018hyperferritinemic syndrome\u2019, which already includes adult-onset Still\u2019s disease, macrophage activation syndrome, septic shock and catastrophic anti-phospholipid syndrome.Beware of the same storm that has a different originSome of the articles being published during the severe acute respiratory syndrome\u2013coronavirus (SARS-CoV)-2 pandemic highlight a link between severe forms of coronavirus disease 2019 (COVID-19) and the so-called cytokine storm, also with increased ferritin levels."}